US: BRIBF - Brii Biosciences Limited

半年間の収益性: +7.57%
配当利回り: 0.00%

プロモーションスケジュール Brii Biosciences Limited

詳細なスケジュール 簡易グラフ
Financial Markets by TradingView

会社について Brii Biosciences Limited

Brii Biosciences Limited engages in the research and development of therapies for the treatment of infectious and central nervous system diseases in China and the United States. The company develops BRII-179, BRII-835, and BRII-877, which are in Phase 2 the development of a functional cure for HBV for Hepatitis B; BRII-179, a recombinant protein-based HBV immunotherapeutic candidate that is in Phase 2; and BRII-732 that is in Phase 1 clinical trial and BRII-753, which is in preclinical stage for the treatment of HIV.

さらに詳しく
It develops BRII-296 for the treatment of PPD/MDD, anxiety, and other depressive disorders; BRII-297 for treatment of various depressive disorders; BRII-693 for the treatment of multi-drug resistant/extensive drug resistant (MDR/XDR) gram-negative infections; and BRII-658 for oral treatment for patients with chronic NTM lung disease. Brii Biosciences Limited was incorporated in 2017 and is headquartered in Beijing, China.
比較リストに追加
ウォッチリストに追加
ポートフォリオに追加
価格通知を追加

Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета cny
Сайт https://www.briibio.com
Цена ао 0.1346
1日あたりの価格変動: +0.2972% (0.1346)
週ごとの価格変動: +0.2972% (0.1346)
月ごとの料金変更: +0.2972% (0.1346)
3ヶ月間の価格変動: +7.57% (0.1255)
半年間の価格変動: +7.57% (0.1255)
年間の価格変動: -41.28% (0.2299)
3年間の価格推移: -93.81% (2.18)
5年間の価格推移: 0% (0.135)
10年間の価格推移: 0% (0.135)
年初からの価格変動: +7.57% (0.1255)
すべてのパラメータ

過小評価

名前 意味 学年
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
合計: 2.5

効率

名前 意味 学年
ROA, % 0 0
ROE, % 0 0
合計: 0

配当金

名前 意味 学年
Div yield, % 0 0
DSI 0 0
合計: 0

義務

名前 意味 学年
Debt/EBITDA 0 10
合計: 10

成長の衝動

名前 意味 学年
収益性 Revenue, % -78.73 0
収益性 Ebitda, % -67.51 0
収益性 EPS, % -95.34 0
合計: 2
さらに詳しく

スーパーバイザー 役職 支払い 生年
Dr. Zhi Hong Ph.D. Co-founder, Executive Chairman of the Board & CEO 1964 (61 年)
Dr. Ankang Li C.F.A., J.D., Ph.D. Chief Financial & Strategy Officer, Company Secretary and Executive Director 1979 (46 年)
Dr. Eleanor de Groot Ph.D. Chief Technology Officer 1969 (56 年)
Dr. Brian Alvin Johns Ph.D. Chief Scientific Officer
Sarah Qiu Associate Director of Investor Relations
Ms. Karen Del Barrio Neuendorff Chief People Officer & Head of Human Resources 1976 (49 年)
Mr. Coy Stout Head of Patient Advocacy 1972 (53 年)
Dr. Lianhong Xu Ph.D. Head of Discovery 1967 (58 年)
Dr. Qing Zhu Ph.D. Head of China Research & Development 1968 (57 年)
Dr. David Margolis M.D., M.P.H. Chief Medical Officer 1975 (50 年)

住所: China, Beijing, Building 7 International Science Park - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.briibio.com